rges peptide has been researched along with sq-23377 in 1 studies
| Studies (rges peptide) | Trials (rges peptide) | Recent Studies (post-2010) (rges peptide) | Studies (sq-23377) | Trials (sq-23377) | Recent Studies (post-2010) (sq-23377) |
|---|---|---|---|---|---|
| 27 | 0 | 0 | 4,385 | 10 | 493 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirt, UA; Leist, M | 1 |
1 other study(ies) available for rges peptide and sq-23377
| Article | Year |
|---|---|
Rapid, noninflammatory and PS-dependent phagocytic clearance of necrotic cells.
Topics: Animals; Annexin A5; Antibodies, Monoclonal; Apoptosis; Calcium; CD36 Antigens; Cell Line; Cell Membrane; Cells, Cultured; Escherichia coli; Formaldehyde; Humans; Inflammation; Ionomycin; Jumonji Domain-Containing Histone Demethylases; Jurkat Cells; Lipopolysaccharide Receptors; Liposomes; Macrophages; Membrane Lipids; Mice; Microglia; Microscopy, Confocal; Microscopy, Fluorescence; Necrosis; Oligomycins; Oligopeptides; Phagocytosis; Phosphatidylserines; Polymers; Receptors, Cell Surface; Staurosporine; Tumor Necrosis Factor-alpha | 2003 |